expr:class='"loading" + data:blog.mobileClass'>

Thursday, 11 April 2019

Health: Can We Stop Hepatitis B?

Hepatitis B still affects more than 257 million people worldwide. 900,000 die each year, particularly in Africa, where 6% of the adult population is infected.
A vaccine exists, however, but it is not used enough.
It is for this reason that a call from the international scientific community is launched this Wednesday, April 10 in the prestigious medical journal The Lancet. Objective: to finally mobilize funds to overcome this disease.

Hepatitis B is an infection of the liver that can degenerate into cirrhosis or cancer if left untreated. And precisely, it is little. "  Hepatitis B is a disease for which we have had a vaccine for several decades. And we naively thought that from the moment we have a vaccine, it was enough to vaccinate all generations to come and that things would eventually settle. In fact, we have never vaccinated enough to be able to really control the epidemic, so today we have 250 million people living with this virus. It is therefore imperative to find ways to treat them and if possible to cure them,  " says Fran├žois Dabis, the boss of the ANRS, the National Agency for Research against AIDS and viral hepatitis.

We know how to treat hepatitis B, but we do not know how to cure it. It is necessary to amplify the research. This is the subject of this call published Wednesday, April 10 in The Lancet: "Today, it is about launching a major international initiative to really launch more the issue of vaccination, treat more people, and especially innovate with research. Seeking ways to heal people living with hepatitis B as quickly as possible."

At the heart of the debate, the money obviously to finance these new research
A request that comes from the base, scientists themselves. It remains to be seen, so if this call will be heard.

No comments:

Post a Comment